EUVIMEDEUVIMED entdecken
Crossref

Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐ LIGHT study

Khaled M Musallam iD, Angela Vitrano iD, Alessandro Inzerillo, Rosario Di Maggio iD, Rita Barone, Antonino Giangreco, Maria Concetta Renda iD, Emanuela Fecarotta, Antonio Troia, Antonino Giambona iD, Giovan Battista Ruffo, Efthymia Vlachaki iD und 8 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Khaled M Musallam und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research on Rare Blood Disorders (CR-RBD) and Thalassemia & Sickle Cell Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: beta-Thalassemia, Iron, Anemia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Agios Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence on the impact of anaemia and iron control on morbidity and mortality in β‐thalassaemia is limited to short‐term studies assessing spot measures. We conducted a retrospective longitudinal cohort study of 557 patients with β‐thalassaemia followed from diagnosis for a median of 38 years. There was a significant association between the lifetime proportion spent on transfusion and thalassaemia‐related mortality (adjusted hazard ratios (HR) 0.987 for each 1‐percent increase, p = 0.014). In both patients with non‐transfusion‐dependent β‐thalassaemia (NTDT) and transfusion‐dependent β‐thalassaemia (TDT) (lifetime proportion on transfusion ≤70% and >70%, respectively), there was a significant association between a lifetime anaemia and iron control index (LAICI) and mortality (NTDT: adjusted HR 0.916 for each 1‐point increase, p = 0.017; TDT: adjusted HR 0.672, p = 0.027). Survival was significantly lower in patients with suboptimal than optimal LAICI, defined based on international NTDT and TDT guidelines for anaemia and iron overload management (NTDT: adjusted HR 0.395, p = 0.046; TDT: adjusted HR 0.205, p = 0.020 for optimal vs. suboptimal LAICI). Patients with optimal LAICI had significantly lower odds of cardiac (NTDT, TDT), vascular (TDT), hepatic (NTDT), endocrine morbidity (NTDT, TDT) and osteoporosis (NTDT). Optimal anaemia and iron control throughout the entire disease course are essential to reduce morbidity and mortality in patients with β‐thalassaemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaIronAnemiaHumansMaleFemaleAdultLongitudinal StudiesRetrospective StudiesMiddle AgedBlood TransfusionIron OverloadAdolescentYoung Adult

Stichwörter der Autor:innen

haemoglobinmorbiditymortalityserum ferritintransfusion

Substanzen

Iron

Autor:innen und Institutionen

  • Center for Research on Rare Blood Disorders (CR-RBD) and Thalassemia & Sickle Cell Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Department of Public Health & Epidemiology, Khalifa University, Abu Dhabi, United Arab Emirates.
  • Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
  • Campus of Haematology Franco and Piera Cutino, UOC Ematologia per le Malattie Rare Del Sangue e degli Organi Ematopoietici, AOOR Villa Sofia-V. Cervello, Palermo, Italy.
  • Laboratorio Biobanca, UOC Ematologia per le Malattie Rare Del Sangue e degli Organi Ematopoietici, Palermo, Italy.
  • UOSD Diagnostica Molecolare Malattie Rare Ematologiche, AOOR Villa Sofia-Cervello, Palermo, Italy.

ORCID-Profile: Khaled M Musallam, Angela Vitrano, Rosario Di Maggio, Maria Concetta Renda, Antonino Giambona, Efthymia Vlachaki, Paolo Ricchi, Filomena Longo, Aurelio Maggio

Förderung

  • Agios Pharmaceuticals

Zitieren

APA

Musallam, K. M., Vitrano, A., Inzerillo, A., Di Maggio, R., Barone, R., Giangreco, A., Renda, M. C., Fecarotta, E., Troia, A., Giambona, A., Ruffo, G. B., Vlachaki, E., Venou, T. M., Ricchi, P., Ziello, B., Serra, M., Colizzi, E., Longo, F., Culcasi, M., & Maggio, A. (2025). Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐ LIGHT study. British Journal of Haematology. https://doi.org/10.1111/bjh.70047

Vancouver

Musallam KM, Vitrano A, Inzerillo A, Di Maggio R, Barone R, Giangreco A, et al. Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐ LIGHT study. British Journal of Haematology. 2025. doi:10.1111/bjh.70047

BibTeX
@article{Musallam2025,
  author = {Musallam, Khaled M and Vitrano, Angela and Inzerillo, Alessandro and Di Maggio, Rosario and Barone, Rita and Giangreco, Antonino and Renda, Maria Concetta and Fecarotta, Emanuela and Troia, Antonio and Giambona, Antonino and Ruffo, Giovan Battista and Vlachaki, Efthymia and Venou, Theodora M and Ricchi, Paolo and Ziello, Brunella and Serra, Marilena and Colizzi, Elena and Longo, Filomena and Culcasi, Martina and Maggio, Aurelio},
  title = {Impact of lifetime anaemia and iron control on outcomes in β‐thalassaemia: Data from the longitudinal de‐ LIGHT study},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70047}
}
Kostenlos starten →